Steve Schonfeld’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.8M Buy
+857,728
New +$10.6M 0.04% 448
2025
Q3
– Sell
-24,475
Closed -$368K – 2510
2025
Q2
$368K Buy
+24,475
New +$350K ﹤0.01% 1636
2023
Q4
– Sell
-101,000
Closed -$1.35M – 2161
2023
Q3
$1.35M Buy
101,000
+1,500
+2% +$20.3K 0.01% 926
2023
Q2
$1.26M Buy
99,500
+75,500
+315% +$881K 0.01% 906
2023
Q1
$273K Buy
+24,000
New +$259K ﹤0.01% 1410
2021
Q2
– Sell
-24,000
Closed -$295K – 2244
2021
Q1
$295K Buy
+24,000
New +$308K ﹤0.01% 1335
2017
Q2
– Sell
-42,425
Closed -$341K – 742
2017
Q1
$341K Buy
+42,425
New +$366K 0.03% 443

Other funds holding RDY

Steve Schonfeld's RDY Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2026: 857,728 shares worth $10.8M. The stake represents 0.04% of the portfolio and ranks #448 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in RDY as recently as Q2 2025.

Steve Schonfeld first reported a position in RDY in Q1 2017 and has held it in 7 quarters since. 232 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • Steve Schonfeld held 857,728 shares of Dr. Reddy's Laboratories worth $10.8M as of Q3 2026.
  • Dr. Reddy's Laboratories was a new Steve Schonfeld position in Q3 2026.
  • Dr. Reddy's Laboratories made up 0.04% of Steve Schonfeld's portfolio in Q3 2026, its #448 holding.
  • Steve Schonfeld first reported a position in Dr. Reddy's Laboratories in Q1 2017 and has held it in 7 quarters since.
  • 232 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.